Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Novel series of alpha4beta1/alpha4beta7 antagonists claimed by Merck

Dec. 11, 2002

Aeolus and Duke University claim porphyrin-based antioxidants for pulmonary inflammatory diseases

Dec. 10, 2002

Celltech returns rights to CF program to Targeted Genetics

Dec. 5, 2002

Bayer describes inhibitors of PDE7B for asthma and bone disorders

Dec. 5, 2002

Results of Zyrtec study in children with atopic dermatitis

Dec. 3, 2002

Preclinical profile of MEN-91507, a candidate for the treatment of inflammatory diseases

Dec. 2, 2002

FDA approves OTC Claritin for allergies, approvable letter for hives

Dec. 2, 2002

CJ-13610: design of an orally active and safe 5-LO inhibitor

Nov. 28, 2002

PDE4 and/or PDE7 inhibitors identified at Altana Pharma

Nov. 27, 2002

Inflazyme and Aventis expand respiratory drug development collaboration

Nov. 25, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...